Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

Surgical Pioneer Alan Hemming, MD, to Launch Groundbreaking Treatment Center for Liver Disease at UC San Diego

 

October 27, 2009  |   

Distinguished transplant and cancer surgeon, Alan Hemming, MD, has been recruited to the University of California, School of Medicine to launch a multidisciplinary center for the treatment of advanced liver disease at the UC San Diego Medical Center and Moores UC San Diego Cancer Center. This innovative program is designed to offer adult and pediatric patients in the western United States a single destination for the treatment of complex liver disease, from advanced diagnostics to experimental medical therapies and novel approaches for liver resection and transplantation.

Alan Hemming

Alan Hemming, MD, is one of the few surgeons in the country who has treated unresectable liver cancer by temporarily removing the patient’s entire liver for reconstruction

“Whether you are suffering from liver failure, or primary or secondary liver malignancy, there are new combinations of treatment that can be delivered to you at UCSD Medical Center,” said Hemming, professor of surgery and Chief of Transplantation and Hepatobiliary Surgery. “If you have been told that you have untreatable liver disease, there is hope for you here. As a world-recognized academic medical center, UC San Diego has the expertise, resources and skill to take on the most difficult cases.”

Known for his lifesaving surgical skills, Hemming is one of the few surgeons in the country who has treated otherwise unresectable liver cancer by temporarily removing the patient’s entire liver for reconstruction. After removing and cooling the liver, Hemming performs the meticulous process of tumor removal and blood supply reconstruction. Upon completion, the tumor-free liver is “re-implanted” into the body. This novel form of resection provides the possibility of cure for patients with few other options.

Watch a Video of Dr. Hemming

Watch a video of Dr. Hemming discussing treatments for liver disease

Hemming has performed more than 500 liver transplants such as split, living-related, and domino procedures, including a successful liver transplant for one of the smallest recipients in the world – an infant weighing just over four pounds. A gifted surgeon, Hemming has performed more than 900 liver resections. He specializes in all aspects of hepatobiliary surgery including both open and laparoscopic liver resection for tumors, resection of the pancreas and bile duct, and portal decompressive procedures.

“The San Diego region is now home to one of the United States’ leading surgeon-scientists in the field of transplantation,” said Mark Talamini, MD, professor and chair of the department of surgery at UCSD Medical Center. “Bringing together an internationally recognized team of surgeons, radiologists, gastroenterologists, hepatologists, oncologists and nurses, Hemming’s vision is to offer patients a customized path to treatment for every form and stage of liver disease.”

Among Hemming’s plans are to develop an adult living donor program for liver transplant, an expanded program for primary and metastatic liver cancer and a clinical research program to explore new technologies and their application to liver surgery. He was recently co-principle investigator in an assessment of image-guided liver surgery with Memorial Sloan Kettering Cancer Center and the University of Pittsburgh Medical Center. His plans include bringing the development of such new technologies to UCSD.

Prior to coming to UC San Diego, Hemming was the Chief of Transplantation and Hepatobiliary Surgery at the University of Florida where he developed one of the nation’s fastest growing treatment centers for hepatobiliary disease. Under his leadership, the program’s surgeons were able to aggressively resect and cure up to a third of patients who had been identified as unresectable by other institutions.

Hemming earned his medical degree from and completed his general surgery residency at the University of British Columbia in Vancouver, British Columbia. He completed his internship at St. Michael’s Hospital in Toronto. He completed fellowship training in both hepatopancreaticobiliary surgery and liver transplantation from the University of Toronto, Toronto Hospital in Ontario.

An NIH-funded researcher, Hemming is named to both America’s Top Doctors for Cancer as well as America’s Top Doctors. He has authored multiple book chapters and more than 100 peer-reviewed publications in the areas of advanced liver surgery techniques, liver transplantation and the care of patients with hepatobiliary disease.

Hemming currently sits on the ethics committee of the American Society of Transplant Surgeons. He is also member of the American Surgical Association, the Southern Surgical Association, the Society of Surgical Oncology, and the American Hepatopancreaticobiliary Association.

# # #

Media Contact: Jackie Carr, 619-543-6163, jcarr@ucsd.edu



Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...